NCT06533787 Impact of Echocardiography on Management of Critically Ill Neonates
| NCT ID | NCT06533787 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sahar Abozkaly Mahmoud |
| Condition | Critical Illness |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-08-01 |
| Primary Completion | 2025-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2024-08-01 with a primary completion date of 2025-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of the study was to estimate the outcome (mortality and morbidity) among hemodynamically unstable neonates, as well as the time to return to hemodynamic stability following the use of ECHO in the management of hemodynamically unstable neonates.
Eligibility Criteria
Inclusion Criteria: * All neonates ( age 0 to 28 days) admitted to the NICU of Sohag University Hospital during the period of the study in whom manifestations of hemodynamic instability or critical illness were elected regardless of gestational age, weight, gender, or type of disease. Exclusion Criteria: * Failure to obtain informed consent . * Presence of congenital heart disease apart from PDA , PFO \& small ASD .
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06533787 clinical trial?
This trial is open to participants of all sexes, aged 2 Hours or older, up to 28 Days, studying Critical Illness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06533787 currently recruiting?
Yes, NCT06533787 is actively recruiting participants. Contact the research team at sahar.abozakaly@med.sohag.edu.eg for enrollment information.
Where is the NCT06533787 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT06533787 clinical trial?
NCT06533787 is sponsored by Sahar Abozkaly Mahmoud. The trial plans to enroll 50 participants.